
|Articles|June 1, 2001
The American Journal of Managed Care
- June 2001
- Volume 7
- Issue 6
Effect of Rofecoxib Therapy on Measures of Health-Related Quality of Life in Patients with Osteoarthritis
Advertisement
Articles in this issue
over 24 years ago
Does the HEDIS Asthma Measure Go Far Enough?over 24 years ago
Rheumatoid Arthritis: Guidelines for Emerging TherapiesNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure
2
Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?
3
KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials: Christof Vulsteke, MD, PhD
4
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
5